TG Therapeutics (TGTX) Reports Q3 Loss of $0.43
Tweet
Share
E-mailGet Alerts TGTX Hot Sheet
Join SI Premium – FREE
TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.43), versus ($0.48) reported last year.
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
- AXT appoints Tracy Liu to its board of directors
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
